QualityStocksNewsBreaks Archives - Page 1123 of 1497

WednesdaySep 25, 2019 9:49 am

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Tuesday announced that it will report results for the fourth quarter and fiscal year 2019 ending June 30, 2019, on Wednesday, October 23, 2019, at approximately 5:00 PM ET. In addition, Green Growth Brands will host a conference call with company management in conjunction with release of its financial results, with the call slated to take place on Thursday, October 24, 2019, at 8:30 AM ET. Interested parties may join the conference by dialing (+1) 416 764 8609 (Local Toronto), (+1) 778 383 7417 (Local Vancouver) or (+1) 888…

WednesdaySep 25, 2019 9:40 am

QualityStocksNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Closes $8.3M Public Offering; Launches HEMP FX Brand in Japan

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, on Tuesday announced the closing of its underwritten public offering of 333,500 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock, including 43,500 shares pursuant to the exercise of the over-allotment option by the underwriters. The shares were sold at a public offering price of $25.00 each, resulting in gross proceeds of $8,337,500, prior to withholding discount, commissions and estimated offering expenses. The Benchmark Company, LLC acted as sole book-running manager of the offering. In addition, YGYI this morning announced the launch of…

TuesdaySep 24, 2019 11:24 am

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress

RJ Tesi, M.D., co-founder and CEO of clinical-stage immunology company INmune Bio (NASDAQ: INMB), was recently featured in an interview with multimedia financial reporter Jason Lin. Among other highlights, Dr. Tesi discusses recent company accomplishments in the interview. “Nasdaq’s MarketSite is a premiere platform for INmune Bio to share our story with investors and to discuss recent developments in our programs for cancer, Alzheimer’s disease and nonalcoholic steatohepatitis (NASH) liver disease,” INmune co-founder and CEO Dr. RJ Tesi stated in the interview. “We hope to continue reaching new milestones in the development of therapies that target the innate immune system.”…

TuesdaySep 24, 2019 10:47 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF) Recommences Production at Asphalt Ridge Facility

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), a fully integrated surface oil sands clean recovery mining oil company with proprietary technology, today announced its recommencement of production today from the Asphalt Ridge Facility in Utah. According to the update, completion of the planned equipment modifications to the sand separation process, fluid extraction process, and the clean sand production process mark a significant milestone for the company’s proprietary oil extraction solvent technology. "The technology enhancements completed in the last several months are expected to provide the Company the foundation to consistently increase production to its productive capacity in a step…

TuesdaySep 24, 2019 10:15 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts New Line of Best Selling Gummies at Hall of Flowers Cannabis Tradeshow

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company based in California, this morning announced the launch of a new line of its best-selling cannabis-infused gummies*. According to the update, the company unveiled its new line at the Hall of Flowers cannabis tradeshow in Santa Rosa, California this past week, rolling out three new flavors of gummies developed by Plus Products’ team of scientists, entrepreneurs and chefs. The new product line includes a balance cucumber lime with 3.5mg THC and 1.5mg CBD per piece; an uplift tangerine with 5mg THC and <0.1mg CBD per piece; and…

TuesdaySep 24, 2019 10:08 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Posts Update on Washington State Assets

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning posted a shareholder update regarding its Washington State assets. Per the update, the company received an encouraging report from the general manager of its Washington state licensee partner that detailed increases from April of 30% in sales, 36% in crop yield and 100% in retail client stores. Chemistree also announced that Sugarleaf requested extra cultivation facilities at the Sedro Wooley location, on the same turn-key basis as currently in place, so it can double its current capacity and meet the quickly growing demand for Sugarleaf branded products. “These numbers are surpassing my…

TuesdaySep 24, 2019 9:45 am

QualityStocksNewsBreaks – Pacific Rim Cobalt Corp.’s (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced results from its ongoing 2019 shallow drilling program at its flagship Cyclops, nickel/cobalt development project, Indonesia. The drilling is part of a multi-faceted exploration program focused to confirm historical results and guide a project development plan. According to the update, highly anomalous cobalt and nickel were encountered in shallow intersections across a continuous zone overlying the previously reported nickel saprolite mineralization. "The Company is very pleased with this latest round of drill results. The elevated cobalt values are of significant importance, considering the commodity’s recent price increase and the…

MondaySep 23, 2019 10:16 am

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 AAIC Satellite Symposium

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its plans to present at the upcoming Alzheimer’s Association International Conference (“AAIC”) Satellite Symposium to be held in held Sydney, Australia from September 25-27, 2019. According to the update, INmune Bio Director of Neuroscience C.J. Barnum, Ph.D., will present the company’s strategy for treating Alzheimer’s disease at a panel session, along with other global researchers and leaders in the latest therapeutics and developments in clinical research for the disease. “Neuroinflammation is now widely recognized as…

MondaySep 23, 2019 9:45 am

QualityStocksNewsBreaks – B2Digital, Inc. (BTDG) Announces Acquisition of Strike Hard Productions MMA, Provides Business Update

B2Digital (OTC: BTDG) today announced its acquisition of Strike Hard Productions of Alabama, effective immediately, and also provided a business update. Per the terms of the acquisition agreement, B2Digital acquired 100% of the equity interests in Strike Hard Productions for a combination of cash and shares of BTDG’s restricted common stock. “We have been looking for ways to expand Strike Hard Productions in Alabama and Mississippi, and the expertise of B2Digital CEO Greg Bell and the success of the Company’s LIVE events and technologies are why we decided to join the B2 Fighting Series,” Jamie Sullivan, who will remain the…

FridaySep 20, 2019 1:55 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results

Geyser Brands (TSX.V: GYSR) recently reported notable financial results for the eight months ended March 31, 2019 (http://ibn.fm/Dc9Pn). An article discussing the company reads, “‘We are pleased with our progress in the first eight months since completing the RTO. Our subsidiary, 0957203 B.C. Ltd. dba Apothecary Botanicals, through its strong management, has been successful in bringing its facility to GMP-compliant standards for manufacturing and processing and in obtaining Health Canada licensing for Cultivation and Standard Processing,’ Geyser CEO Andreas Thatcher said in a news release. . . . The financial report features a couple of important highlights that stand as…

Site Search

Company Search

Category: QualityStocksNewsBreaks